Tuberculosis (TB), a malevolent bacterial scourge induced by Mycobacterium TB , continues to be a chief reason for morbidity and fatality all over the world. TB is becoming more of an issue due to antibiotic resistance to traditional medications. As a result, there is an increasing and pressing need for new medicines, a task that requires identifying viable drug targets. DprE1, an anti‐TB target, is responsible for mycobacterial cell wall synthesis. Inhibiting DprE1 activity effectively inhibits cell wall biosynthesis and shows great potential as an antitubercular strategy. Macozinone (PBTZ169), derived from the benzothiazinone (BTZ) scaffold, has been extensively investigated as a candidate irreversible covalent inhibitor targeting DprE1. In the current research endeavor, the binding scores of 230 drug candidates containing nitro groups at the investigational or clinical trial stage were evaluated against DprE1 using a covalent docking approach. Based on the available experimental data, the efficacy of the employed covalent docking technique in predicting the DprE1‐drug binding pose was primarily assessed. The drug candidates with binding scores less than macozinone (calc. −7.8 kcal/mol) underwent MD simulations (MDSs), accompanied by binding energy assessments employing the molecular mechanics–generalized Born surface area (MM‐GBSA) approach. In accordance with the MM‐GBSA//250 ns MDS, niludipine (DB09240), DB02051, azelnidipine (DB09230), and manidipine (DB09238) revealed greater binding affinity with Δ G binding values of −58.8, −53.5, −52.6, and −51.3, respectively, than macozinone (calc. −49.4 kcal/mol). Subsequent MD analyses demonstrated excellent conformational stability of the investigated drug candidates bound to DprE1 throughout the 250 ns simulation timeframe. Regarding physicochemical and ADMET characteristics, the four promising drug candidates were bioavailable orally. Generally, these outcomes revealed that niludipine, DB02051, azelnidipine, and manidipine are prospective anti‐TB drug candidates that merit further experimental assays.